INCAGN01876
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for INCAGN01876, covering 2021-02-26 to 2022-12-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies [Phase 1, Phase 2]